Inactive Instrument

News Cornerstone Therapeutics, Inc.

Equities

US21924P1030

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics Inc. Stockholders Approve Merger	28/02/14	PU
Cornerstone Therapeutics Inc. Stockholders Approve Merger	03/02/14	MW
Cornerstone Therapeutics Adjourns Special Meeting of Stockholders	31/01/14	MW
Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics Launches BETHKIS(R) (Tobramycin Inhalation Solution) for Management of Cystic Fibrosis Patients With Pseudomonas Aeruginosa	20/11/13	PU
Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics to Host Third Quarter 2013 Conference Call	31/10/13	PU
Cornerstone Therapeutics, Inc. : Shareholder Rights Law Firm Johnson & Weaver, LLP, is Investigating the Cornerstone Buyout	16/09/13	BU
Cornerstone Therapeutics, Inc. : Law Firm Brower Piven Announces Investigation of Cornerstone Therapeutics, Inc. Proposed Acquisition	16/09/13	BU
Cornerstone Therapeutics, Inc. : Finkelstein Thompson LLP Announces Investigation of Cornerstone Therapeutics Inc. Buyout	16/09/13	BU
Cornerstone Therapeutics, Inc. : Chiesi Farmaceutici and Cornerstone Therapeutics Announce Agreement for a Merger Transaction in Which Chiesi Will Acquire 100 Percent Ownership of Cornerstone for $9.50 per Share in Cash	16/09/13	PU
Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics Reports First Quarter 2013 Financial Results	03/09/13	PU
Cornerstone Therapeutics, Inc. : REMINDER: Cornerstone Therapeutics to Host First Quarter 2013 Conference Call	03/08/13	PU
Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics Sues to Enforce Its CARDENE(R) I.V. Patents	24/07/13	PU
Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics to Host Fourth Quarter and Full Year 2012 Conference Call	01/07/13	PU
Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics Receives CARDENE(R) I.V. (Nicardipine Hydrochloride) Paragraph IV Notice Letter	13/06/13	PU
Cornerstone Therapeutics, Inc. : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Cornerstone Therapeutics Inc. Shareholders	25/02/13	BU
Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics to Acquire EKR Therapeutics, Accelerating Expansion in Hospital Market	15/05/12	PU
Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics Receives FDA Acceptance for CRTX 080 NDA for Treatment of Hyponatremia	13/03/12	PU
CORNERSTONE THERAP : New Research Indicates Treating Neonatal Respiratory Distress Syndrome with CUROSURF® Results in Lower Rate of Mortality Compared to Competitive Surfactants	12/09/11	BU
CORNERSTONE THERAP : Cornerstone Therapeutics to Host Fourth Quarter and Full Year 2010 Conference Call	18/02/11	PR
CORNERSTONE THERAP : Cornerstone Therapeutics to Host Third Quarter 2010 Conference Call	28/10/10	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Cornerstone Therapeutics, Inc.

Equities

US21924P1030

Summary

Filters